Trademark Search in Canada

MINT ANIMAL HEALTH

View On IC.GC.CA

REGISTERED

on 18 Oct 2021

Last Applicant/ Owned by

MINT PHARMACEUTICALS INC.

1093 Meyerside Drive Unit 1Mississauga

ONTARIO

L5T1J6

Serial Number

1896909 filed on 2^th May 2018

Registration Number

TMA1111790 registered on 18^th Oct 2021

Registration expiry Date

18^th Oct 2031

Correspondent Address

BLANEY MCMURTRY LLP

Suite 15002 Queen Street EastToronto

ONTARIO

M5C3G5

MINT ANIMAL HEALTH

Trademark usage description

chemicals for use as intermediates in the manufacture of pharmaceutically active compounds and for use as active ingredients in the manufacture of pha Read More

Classification Information

Class [001]
Chemicals for use as intermediates in the manufacture of pharmaceutically active compounds and for use as active ingredients in the manufacture of pharmaceutical preparations

Classification kind code

Class [003]
Skin care preparations

Classification kind code

Class [005]
Pharmaceutical preparations, namely, analgesics, antiallergic medicines, anticoagulants, anti-diabetic pharmaceuticals, antihypertensives, diuretics, fungal medications, muscle relaxants, hypnotics, nausea treatment medications, anti-inflammatory preparations, nonsteroidal anti-inflammatory drugs, nonsteroidal anti-rheumatic drugs, pharmaceutical preparations for reducing cholesterol, pharmaceutical preparations for the treatment of hyperlipidemia, pharmaceutical preparations for the treatment of allergic rhinitis, asthma treatment preparations, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the prevention of cancer, pharmaceutical preparations for the treatment of cardiovascular diseases, cardiovascular pharmaceutical preparations, pharmaceutical preparations for the treatment of erectile dysfunction, pharmaceutical preparations for the treatment of gastrointestinal disorders and gastrointestinal diseases, pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections, pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, cerebrovascular accident (stroke), pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, pharmaceutical preparations for use in dermatology, namely, dermatitis, psoriasis, sexually transmitted diseases, pharmaceutical preparations for the prevention of osteoporosis, pharmaceutical preparations for ophthalmological use, pharmaceutical preparations for the treatment of glaucoma, pharmaceutical preparations for the treatment of disorders of keratinization, acne medications, contraceptive preparations, fertility enhancement preparations for human use, antibiotics, anti-viral agents, pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, pharmaceutical preparations for the treatment of smoking cessation, antihistamines, cough treatment medications, pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia, nervosa, anorexia, obesity and hypothyroidism, antiarrhythmic drugs, antipyretic drugs with sedative effect, antituberculous drugs, antitumor drugs, pharmaceutical preparations for suppressing tumours, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, pharmaceutical cold preparations, pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations and thyroid hormone preparations, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, pharmaceutical preparations for regulating the immune system, pharmaceutical preparations for the treatment of blood disorders, pharmaceutical preparations for the treatment of gout; dietary supplements for general health and well-being; nutritional supplements for general health and well-being; medicinal marijuana for use in the treatment of nausea, vomiting, pain, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, multiple sclerosis, arthritis, Parkinson's disease, cancer, gastrointestinal illness, spinal cord injury, anxiety, bi-polar disorder, depression, and insomnia; medicinal cannabis for use in the treatment of nausea, vomiting, pain, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, multiple sclerosis, arthritis, Parkinson's disease, cancer, gastrointestinal illness, spinal cord injury, anxiety, bi-polar disorder, depression, and insomnia; tetrahydrocannabinol (THC), cannabidiol (CBD), tetrahydrocannabivarin (THV) and cannabinoids; medicinal marijuana in the form of pills, tablets, capsules, transdermal patches, topical creams, gels, nasal sprays, suppositories, sublingual doses, mucus membrane doses, film strips, liquids, powders, all for use in the treatment of nausea, vomiting, pain, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, multiple sclerosis, arthritis, Parkinson's disease, cancer, gastrointestinal illness, spinal cord injury, anxiety, bi-polar disorder, depression, and insomnia; medicinal cannabis in the form of pills, tablets, capsules, transdermal patches, topical creams, gels, nasal sprays, suppositories, sublingual doses, mucus membrane doses, film strips, liquids, powders, all for use in the treatment of nausea, vomiting, pain, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, multiple sclerosis, arthritis, Parkinson's disease, cancer, gastrointestinal illness, spinal cord injury, anxiety, bipolar disorder, depression, and insomnia; pharmaceutical preparations containing tetrahydrocannabinol (THC), pharmaceutical preparations containing cannabidiol (CBD), pharmaceutical preparations containing tetrahydrocannabivarin (THV), pharmaceutical preparations containing cannabinoids, all for use in the treatment of nausea, vomiting, pain, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, multiple sclerosis, arthritis, Parkinson's disease, cancer, gastrointestinal illness, spinal cord injury, anxiety, bipolar disorder, depression, and insomnia; dietary and nutritional supplements containing cannabis extracts, dietary and nutritional supplements containing cannabis oil, dietary and nutritional supplements containing tetrahydrocannabinol (THC), dietary and nutritional supplements containing cannabidiol (CBD), dietary and nutritional supplements containing tetrahydrocannabivarin (THV), dietary and nutritional supplements containing cannabinoids; animal feed supplements; animal vitamins; anti-infective preparations for veterinary purposes; antibiotics for veterinary purposes; biochemical preparations for veterinary purposes; diagnostic reagents for veterinary purposes; hormones for veterinary purposes; insecticidal veterinary washes; pain relief medication for veterinary purposes; veterinary vaccines

Classification kind code

Class [010]
Lice combs

Classification kind code

Class [016]
Pharmaceutical information leaflets

Classification kind code

Class [029]
Meats and processed foods

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [030]
Food products containing cannabis, namely chocolates, cookies, brownies, pastries, cakes, candy and food energy bars, food products containing hashish, namely, chocolates, cookies, brownies, pastries, cakes, candy and food energy bars, food products containing cannabis resins, namely, chocolates, cookies, brownies, pastries, cakes, candy and food energy bars, food products containing cannabis oil, namely, chocolates, cookies, brownies, pastries, cakes, candy and food energy bars

Classification kind code

Class [031]
Edible treats for pets

Classification kind code

Class [034]
Dried cannabis, dried marijuana, cannabis oil, cannabis extracts, namely, hashish, resins, and oils" has been revised to "dried cannabis; dried marijuana; cannabis extracts, namely, hashish, resins, cannabidiol [CBD] and tetrahydrocannabinol [THC] oil for electronic cigarettes; cannabis extracts, namely, hashish, resins, cannabidiol [CBD] and tetrahydrocannabinol [THC] oil for vaporizers for smoking

Classification kind code

Class [035]
Wholesale services for pharmaceutical preparations and medical supplies; wholesale services of veterinary preparations; wholesale services of dietary supplements for general health and well-being, wholesale services of nutritional supplements for general health and well-being; sales of medical supplies of others; promoting pharmaceutical preparations and medical supplies of others by advertising and direct marketing of the pharmaceutical preparations and medical supplies of others; sales of medicinal marijuana, non-medicinal marijuana, medicinal cannabis, non-medicinal cannabis, dried marijuana, dried cannabis, cannabis oil, tetrahydrocannabinol (THC), cannabidiol (CBD), tetrahydrocannabivarin (THV), cannabinoids, cannabis seeds, cannabis clones, live cannabis plants, cannabis extracts, tinctures, pastes and salves, pharmaceutical preparations containing tetrahydrocannabinol (THC), pharmaceutical preparations containing cannabidiol (CBD), pharmaceutical preparations containing tetrahydrocannabivarin (THV), pharmaceutical preparations containing cannabinoids, dietary and nutritional supplements containing cannabis extracts, dietary and nutritional supplements containing cannabis oil, dietary and nutritional supplements containing tetrahydrocannabinol (THC), dietary and nutritional supplements containing cannabidiol (CBD), dietary and nutritional supplements containing tetrahydrocannabivarin (THV), dietary and nutritional supplements containing cannabinoids, food products containing cannabis, namely chocolates, cookies, brownies, pastries, cakes, candy and food energy bars, food products containing hashish, namely, chocolates, cookies, brownies, pastries, cakes, candy and food energy bars, food products containing cannabis resins, namely, chocolates, cookies, brownies, pastries, cakes, candy and food energy bars, food products containing cannabis oil, namely, chocolates, cookies, brownies, pastries, cakes, candy and food energy bars

Classification kind code

Class [040]
Assembly of pharmaceuticals for others

Classification kind code

Class [042]
Conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical research and development; biomedical research; medical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information in the field of veterinary services; research and development in the field of marijuana, cannabis, tetrahydrocannabinol (THC), cannabidiol (CBD), tetrahydrocannabivarin (THV) and cannabinoids

Classification kind code

Class [044]
Providing pharmaceutical information; advisory and consultancy services in the use of medicinal marijuana, medicinal cannabis, tetrahydrocannabinol (THC), cannabidiol (CBD), tetrahydrocannabivarin (THV) and cannabinoids

Classification kind code

Mark Details

Serial Number

1896909

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 15 on 17^th Mar 2021	Correspondence Created
Submitted for opposition 15 on 24^th Apr 2020	Correspondence Created
Submitted for opposition 15 on 24^th May 2019	Correspondence Created
Submitted for opposition 22 on 12^th Oct 2018	Search Recorded
Submitted for opposition 20 on 12^th Oct 2018	Examiner's First Report
Submitted for opposition 87 on 26^th Jun 2018	Rep for Service Changed
Submitted for opposition 48 on 26^th Jun 2018	Agent Changed
Submitted for opposition 31 on 9^th May 2018	Formalized
Submitted for opposition 1 on 3^rd May 2018	Created
Submitted for opposition 30 on 2^th May 2018	Filed

MINT ANIMAL HEALTH

Classification Information

Class [001]Chemicals for use as intermediates in the manufacture of pharmaceutically active compounds and for use as active ingredients in the manufacture of pharmaceutical preparations

Classification kind code

Class [003]Skin care preparations

Classification kind code

Classification kind code

Class [010]Lice combs

Classification kind code

Class [016]Pharmaceutical information leaflets

Classification kind code

Class [029]Meats and processed foods

Comment text

Classification kind code

Classification kind code

Class [031]Edible treats for pets

Classification kind code

Classification kind code

Classification kind code

Class [040]Assembly of pharmaceuticals for others

Classification kind code

Classification kind code

Class [044]Providing pharmaceutical information; advisory and consultancy services in the use of medicinal marijuana, medicinal cannabis, tetrahydrocannabinol (THC), cannabidiol (CBD), tetrahydrocannabivarin (THV) and cannabinoids

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [001]
Chemicals for use as intermediates in the manufacture of pharmaceutically active compounds and for use as active ingredients in the manufacture of pharmaceutical preparations

Class [003]
Skin care preparations

Class [010]
Lice combs

Class [016]
Pharmaceutical information leaflets

Class [029]
Meats and processed foods

Class [031]
Edible treats for pets

Class [040]
Assembly of pharmaceuticals for others

Class [044]
Providing pharmaceutical information; advisory and consultancy services in the use of medicinal marijuana, medicinal cannabis, tetrahydrocannabinol (THC), cannabidiol (CBD), tetrahydrocannabivarin (THV) and cannabinoids